Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02440815 · ClinicalTrials.gov registry record · NA

Multimodal MRI Characteristics of Psychotherapy Response in Late Life Depression

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
108
Enrollment target

NCT02440815 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 108 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02440815, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
108 participants
Enrollment target

Study Summary

The specific focus of this study is to gather data regarding the effects of a psychological therapy known as Problem Solving Therapy (PST) on cerebral blood flow (CBF), cortical gray matter (GM) atrophy, subcortical white matter (WM) lesion burden, and measures of cognitive function in subjects with Late Life Major Depressive Disorder (LLD). This research goal will be achieved by recruiting 110 individuals over the age of 65 with LLD. The primary outcomes will be change in CBF, change in GM atrophy, change in WM lesion, change in cognitive function, and change in depression severity from baseline to the end of 12 weeks of PST.

Interventions

  • BEHAVIORAL Problem Solving Therapy

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2015-11
Est. Completion 2021-07-28
Phase NA

What the Registry Record Tells You About NCT02440815

The ClinicalTrials.gov registry entry for NCT02440815 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Problem Solving Therapy is the first listed.

NCT02440815 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02440815 about?

NCT02440815 is a clinical study titled "Multimodal MRI Characteristics of Psychotherapy Response in Late Life Depression". The specific focus of this study is to gather data regarding the effects of a psychological therapy known as Problem Solving Therapy (PST) on cerebral blood flow (CBF), cortical gray matter (GM) atrophy, subcortical white matter (WM) lesion burden, and measures of cognitive function in subjects with...

What is the current status of trial NCT02440815?

This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2015-11. Estimated completion is 2021-07-28.

What interventions are being tested in trial NCT02440815?

The interventions under investigation include: Problem Solving Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT02440815?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.